Answers are grounded in this paper and cite their sources.
Elevated circulating trimethylamine N-oxide (TMAO) is a well-established biomarker of cardiorenal risk; however, accumulating evidence reveals a “causality paradox” that supports a paradigm shift toward the integrated trimethylamine (TMA)–TMAO axis. Rather than acting solely as a downstream metabolite, TMAO serves as a context-dependent indicator of diet–gut microbiota–liver–kidney interactions, whereas gut microbiota-derived TMA functions as a proximal bioactive mediator of vascular toxicity, at least in part through TAAR5 activation, thereby contributing to the initiation of cardiorenal injury. This revised framework helps resolve the “fish paradox” and distinguishes systemic biomarker concentrations from localized, tissue-specific pathogenic processes. This narrative review examines the TMA–TMAO axis through a life-course and Developmental Origins of Health and Disease (DOHaD) perspective, highlighting how maternal chronic kidney disease (CKD) and altered prenatal metabolite exposure can program hypertension and kidney disease in offspring. We further discuss the limitations of relying on static plasma TMAO concentrations, which reflect the combined influences of dietary intake, hepatic flavin monooxygenase activity, gut microbial metabolism, and impaired renal clearance. To overcome these limitations, we advocate dynamic, flux-based metabolic assessment using integrated measurements and ratios of TMA, TMAO, and dimethylamine (DMA). Finally, we propose a four-stage cyclic precision medicine framework that emphasizes early identification of high-risk individuals during critical developmental windows, longitudinal monitoring of systemic toxic burden using rapid and cost-effective point-of-care nanozyme assays, measurement of metabolic flux rather than static metabolite concentrations, and personalized intervention through multimodal strategies, including dietary and prebiotic modulation, non-lethal microbial choline TMA-lyase inhibitors, and computational digital twins for predictive risk stratification. Collectively, shifting the focus from isolated metabolites to the integrated TMA–TMAO axis provides a mechanistically informed, life-course strategy for precision prevention and potential intergenerational influences on cardiorenal health.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: